# Paclitaxel protein-bound particles for injectable suspension (albumin-bound)

NDC: 68001-651
Generic name: Paclitaxel
Labeler / Manufacturer: BluePoint Laboratories
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION
Routes: INTRAVENOUS
Marketing started: 20250718

FDA application: ANDA216355

## Active ingredients

- PACLITAXEL: 100 mg/20mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"68001-651"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=68001-651
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=36d4a2ed-4b34-4b06-e063-6394a90acc86